Fujian Wanchen Biotechnology Group Future Growth
Future criteria checks 6/6
Fujian Wanchen Biotechnology Group is forecast to grow earnings and revenue by 83.3% and 38.9% per annum respectively. EPS is expected to grow by 82.6% per annum. Return on equity is forecast to be 41.6% in 3 years.
Key information
83.3%
Earnings growth rate
82.6%
EPS growth rate
| Food earnings growth | 22.3% |
| Revenue growth rate | 38.9% |
| Future return on equity | 41.6% |
| Analyst coverage | Low |
| Last updated | 08 Nov 2024 |
Recent future growth updates
Recent updates
Fujian Wanchen Biotechnology Group's (SZSE:300972) Strong Earnings Are Of Good Quality
Nov 04
Fujian Wanchen Biotechnology Group Co., Ltd. (SZSE:300972) Stock Rockets 28% But Many Are Still Ignoring The Company
Oct 01Return Trends At Fujian Wanchen Biotechnology Group (SZSE:300972) Aren't Appealing
Sep 30We Think Fujian Wanchen Biotechnology Group (SZSE:300972) Is Taking Some Risk With Its Debt
Aug 04Sentiment Still Eluding Fujian Wanchen Biotechnology Group Co., Ltd. (SZSE:300972)
Jun 06Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 60,733 | 821 | N/A | 2,382 | 1 |
| 12/31/2025 | 47,061 | 510 | N/A | 1,685 | 2 |
| 12/31/2024 | 30,970 | 204 | N/A | 1,178 | 2 |
| 9/30/2024 | 25,006 | 58 | 1,869 | 2,056 | N/A |
| 6/30/2024 | 17,992 | -76 | 1,383 | 1,590 | N/A |
| 3/31/2024 | 13,362 | -129 | 1,035 | 1,270 | N/A |
| 12/31/2023 | 9,294 | -83 | 804 | 1,023 | N/A |
| 9/30/2023 | 5,091 | -46 | -320 | -65 | N/A |
| 6/30/2023 | 2,564 | 40 | -298 | 30 | N/A |
| 3/31/2023 | 1,194 | 76 | -256 | 57 | N/A |
| 1/1/2023 | 549 | 48 | -246 | 70 | N/A |
| 9/30/2022 | 546 | 82 | -66 | 128 | N/A |
| 6/30/2022 | 471 | 38 | 0 | 89 | N/A |
| 3/31/2022 | 448 | 25 | 6 | 81 | N/A |
| 1/1/2022 | 435 | 23 | 57 | 99 | N/A |
| 9/30/2021 | 371 | 4 | 38 | 87 | N/A |
| 6/30/2021 | 399 | 33 | 66 | 122 | N/A |
| 3/31/2021 | 417 | 65 | 111 | 157 | N/A |
| 12/31/2020 | 450 | 96 | 100 | 156 | N/A |
| 9/30/2020 | 449 | 101 | 115 | 162 | N/A |
| 6/30/2020 | 460 | 110 | 133 | 171 | N/A |
| 3/31/2020 | 483 | 130 | 155 | 198 | N/A |
| 12/31/2019 | 451 | 92 | 138 | 177 | N/A |
| 9/30/2019 | 442 | 82 | N/A | N/A | N/A |
| 6/30/2019 | 418 | 74 | 114 | 151 | N/A |
| 3/31/2019 | 358 | 28 | N/A | N/A | N/A |
| 1/1/2019 | 343 | 35 | -23 | 102 | N/A |
| 9/30/2018 | 298 | 15 | N/A | N/A | N/A |
| 6/30/2018 | 258 | -3 | N/A | 63 | N/A |
| 3/31/2018 | 265 | 24 | N/A | N/A | N/A |
| 1/1/2018 | 247 | 16 | N/A | 57 | N/A |
| 9/30/2017 | 259 | 31 | N/A | N/A | N/A |
| 6/30/2017 | 267 | 46 | N/A | 100 | N/A |
| 3/31/2017 | 254 | 52 | N/A | N/A | N/A |
| 12/31/2016 | 220 | 39 | N/A | 80 | N/A |
| 9/30/2016 | 189 | 40 | N/A | 59 | N/A |
| 6/30/2016 | 157 | 30 | N/A | 40 | N/A |
| 3/31/2016 | 157 | 31 | N/A | 49 | N/A |
| 12/31/2015 | 157 | 33 | N/A | 58 | N/A |
| 9/30/2015 | 149 | 30 | N/A | 48 | N/A |
| 6/30/2015 | 160 | 37 | N/A | 68 | N/A |
| 3/31/2015 | 145 | 35 | N/A | 67 | N/A |
| 12/31/2014 | 130 | 34 | N/A | 66 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 300972's forecast earnings growth (83.3% per year) is above the savings rate (2.8%).
Earnings vs Market: 300972's earnings (83.3% per year) are forecast to grow faster than the CN market (26.2% per year).
High Growth Earnings: 300972's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: 300972's revenue (38.9% per year) is forecast to grow faster than the CN market (13.9% per year).
High Growth Revenue: 300972's revenue (38.9% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 300972's Return on Equity is forecast to be very high in 3 years time (41.6%).